Finance

Beta
Lists
6534:TPE
CH Biotech R&D Co Ltd
NT$90.70
-0.66%
(-0.60) 1D
Jun 5, 1:30:29 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6534...
Open
NT$91.10
High
NT$92.00
Low
NT$90.20
Mkt. cap
9.32B
Avg. vol.
170.59K
Volume
103.41K
Dividend
5.29%
Quarterly dividend
NT$1.20
Ex-dividend date
Aug 21, 2025
P/E ratio
19.09
52-wk high
NT$123.50
52-wk low
NT$75.90
EPS
NT$4.75
No. of employees
22
Open
NT$91.10
High
NT$92.00
Low
NT$90.20
Mkt. cap
9.32B
Avg. vol.
170.59K
Volume
103.41K
Dividend
5.29%
Quarterly dividend
NT$1.20
Ex-dividend date
Aug 21, 2025
P/E ratio
19.09
52-wk high
NT$123.50
52-wk low
NT$75.90
EPS
NT$4.75
No. of employees
22
News stories
From sources across the web
About CH Biotech R&D Co Ltd
CEO-
Employees22
Founded2013
Headquarters-
SectorFertilizer
Websitechbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
420.48M
216.68M
328.38M
869.50M
Cost of goods sold
71.75M
44.23M
63.38M
120.11M
Cost of revenue
71.75M
44.23M
63.38M
120.11M
Research and development expenses
90.77M
121.72M
98.86M
99.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.70M
99.03M
124.14M
132.18M
Operating expense
208.89M
221.16M
223.35M
231.23M
Total operating expenses
280.64M
265.39M
286.73M
351.33M
Operating income
139.83M
-48.71M
41.65M
518.17M
Other non operating income
1.26M
1.70M
1.73M
1.08M
EBT including unusual items
32.51M
-21.67M
59.12M
532.25M
EBT excluding unusual items
32.51M
-21.19M
59.24M
532.25M
Income tax expense
-5.16M
-4.69M
15.34M
105.55M
Effective tax rate
-15.88%
21.64%
25.94%
19.83%
Other operating expenses
-
-
-
-
Net income
37.74M
-16.94M
43.80M
426.70M
Net profit margin
8.97%
-7.82%
13.34%
49.07%
Earnings per share
-
-
-
-
Interest and investment income
2.74M
3.86M
2.72M
2.58M
Interest expense
-4.60M
-4.90M
-3.58M
-3.28M
Net interest expenses
-1.86M
-1.04M
-853.00K
-703.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
185.67M
-2.48M
88.81M
566.17M
Gain or loss from assets sale
-
478.00K
122.00K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more